The University of Chicago Header Logo

Connection

Martin Weigert to Animals

This is a "connection" page, showing publications Martin Weigert has written about Animals.
Connection Strength

0.702
  1. B cell receptor light chain repertoires show signs of selection with differences between groups of healthy individuals and SLE patients. Mol Immunol. 2012 Jul; 51(3-4):273-82.
    View in: PubMed
    Score: 0.027
  2. Alternative mechanisms of receptor editing in autoreactive B cells. Proc Natl Acad Sci U S A. 2011 Apr 26; 108(17):7125-30.
    View in: PubMed
    Score: 0.025
  3. Receptor editing: an approach by autoreactive B cells to escape tolerance. The Journal of Experimental Medicine. 1993. 177: 999-1008. J Immunol. 2011 Feb 01; 186(3):1303-12.
    View in: PubMed
    Score: 0.025
  4. Pillars article: generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA, 81: 3180-3184, May 1984. J Immunol. 2008 May 01; 180(9):5765-9.
    View in: PubMed
    Score: 0.021
  5. Reflections on the clonal-selection theory. Nat Rev Immunol. 2007 Oct; 7(10):823-30.
    View in: PubMed
    Score: 0.020
  6. Light chain editing generates polyreactive antibodies in chronic graft-versus-host reaction. J Exp Med. 2006 Jul 10; 203(7):1761-72.
    View in: PubMed
    Score: 0.018
  7. Selection of anti-double-stranded DNA B cells in autoimmune MRL-lpr/lpr mice. J Immunol. 2006 May 01; 176(9):5183-90.
    View in: PubMed
    Score: 0.018
  8. Autoimmunity: The genes and phenotypes of autoimmunity. Curr Opin Immunol. 2004 Dec; 16(6):738-40.
    View in: PubMed
    Score: 0.016
  9. Intricacies of anti-DNA autoantibodies. J Immunol. 2004 Mar 15; 172(6):3367; author reply 3367-8.
    View in: PubMed
    Score: 0.015
  10. Editing anti-DNA B cells by Vlambdax. J Exp Med. 2004 Feb 02; 199(3):337-46.
    View in: PubMed
    Score: 0.015
  11. Regulation of anti-phosphatidylserine antibodies. Immunity. 2003 Feb; 18(2):185-92.
    View in: PubMed
    Score: 0.014
  12. Secondary heavy chain rearrangement: a mechanism for generating anti-double-stranded DNA B cells. J Exp Med. 2003 Jan 06; 197(1):27-39.
    View in: PubMed
    Score: 0.014
  13. Anti-DNA B cells in MRL/lpr mice show altered differentiation and editing pattern. J Exp Med. 2002 Dec 16; 196(12):1543-52.
    View in: PubMed
    Score: 0.014
  14. Analysis of B cell receptor production and rearrangement. Part I. Light chain rearrangement. Semin Immunol. 2002 Jun; 14(3):169-90; discussion 221-22.
    View in: PubMed
    Score: 0.014
  15. D is for different-differences between H and L chain rearrangement. Semin Immunol. 2002 Jun; 14(3):239-41.
    View in: PubMed
    Score: 0.014
  16. Autoreactive B cells in the marginal zone that express dual receptors. J Exp Med. 2002 Jan 21; 195(2):181-8.
    View in: PubMed
    Score: 0.013
  17. Editors and editing of anti-DNA receptors. Immunity. 2001 Dec; 15(6):947-57.
    View in: PubMed
    Score: 0.013
  18. Revising B cell receptors. J Exp Med. 2000 Jun 05; 191(11):1813-7.
    View in: PubMed
    Score: 0.012
  19. Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice. J Exp Med. 1999 Sep 06; 190(5):691-704.
    View in: PubMed
    Score: 0.011
  20. Regulation of anti-DNA B cells in recombination-activating gene-deficient mice. J Exp Med. 1998 Oct 05; 188(7):1247-54.
    View in: PubMed
    Score: 0.011
  21. Fixing mismatches. Science. 1998 Feb 20; 279(5354):1159-60.
    View in: PubMed
    Score: 0.010
  22. Editing disease-associated autoantibodies. Immunity. 1997 Jan; 6(1):97-105.
    View in: PubMed
    Score: 0.009
  23. Self-Antigen-Driven Thymic B Cell Class Switching Promotes T Cell Central Tolerance. Cell Rep. 2016 10 04; 17(2):387-398.
    View in: PubMed
    Score: 0.009
  24. Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. Immunity. 1995 Dec; 3(6):747-55.
    View in: PubMed
    Score: 0.009
  25. Origins of anti-DNA antibodies and their implications for B-cell tolerance. Ann N Y Acad Sci. 1995 Sep 29; 764:384-96.
    View in: PubMed
    Score: 0.009
  26. Constitutive secretion of transgene-encoded IgG2b autoantibodies leads to symptoms of autoimmune disease. J Immunol. 1995 Sep 15; 155(6):3213-22.
    View in: PubMed
    Score: 0.009
  27. Light chain replacement: a new model for antibody gene rearrangement. J Exp Med. 1995 Aug 01; 182(2):541-8.
    View in: PubMed
    Score: 0.009
  28. The site and stage of anti-DNA B-cell deletion. Nature. 1995 Jan 19; 373(6511):252-5.
    View in: PubMed
    Score: 0.008
  29. The mechanism of autoantibody production in an autoimmune MRL/lpr mouse. J Immunol. 1994 Dec 01; 153(11):5104-20.
    View in: PubMed
    Score: 0.008
  30. Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance. J Exp Med. 1994 Nov 01; 180(5):1805-15.
    View in: PubMed
    Score: 0.008
  31. Deletion and editing of B cells that express antibodies to DNA. J Immunol. 1994 Feb 15; 152(4):1970-82.
    View in: PubMed
    Score: 0.008
  32. Light chain editors of anti-DNA receptors in human B cells. J Exp Med. 2014 Feb 10; 211(2):357-64.
    View in: PubMed
    Score: 0.008
  33. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol. 1994; 12:487-520.
    View in: PubMed
    Score: 0.008
  34. A rheumatoid factor transgenic mouse model of autoantibody regulation. Int Immunol. 1993 Oct; 5(10):1329-41.
    View in: PubMed
    Score: 0.008
  35. B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med. 1993 Apr 01; 177(4):1165-73.
    View in: PubMed
    Score: 0.007
  36. Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med. 1993 Apr 01; 177(4):999-1008.
    View in: PubMed
    Score: 0.007
  37. Consideration of the transgenic and other approaches to studying DNA antibodies and their idiotypes. Lupus. 1992 Oct; 1(5):333-4.
    View in: PubMed
    Score: 0.007
  38. Apoptotic marginal zone deletion of anti-Sm/ribonucleoprotein B cells. Proc Natl Acad Sci U S A. 2012 May 15; 109(20):7811-6.
    View in: PubMed
    Score: 0.007
  39. Influence of a V kappa 8 L chain transgene on endogenous rearrangements and the immune response to the HA(Sb) determinant on influenza virus. J Immunol. 1991 Sep 15; 147(6):2024-33.
    View in: PubMed
    Score: 0.007
  40. Intra-Golgi formation of IgM-glycosaminoglycan complexes promotes Ig deposition. J Immunol. 2011 Sep 15; 187(6):3198-207.
    View in: PubMed
    Score: 0.006
  41. Selection of individual VH genes occurs at the pro-B to pre-B cell transition. J Immunol. 2011 Aug 15; 187(4):1835-44.
    View in: PubMed
    Score: 0.006
  42. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature. 1991 Jan 24; 349(6307):331-4.
    View in: PubMed
    Score: 0.006
  43. Ig H and L chain contributions to autoimmune specificities. J Immunol. 1991 Jan 01; 146(1):176-82.
    View in: PubMed
    Score: 0.006
  44. The BALB/c secondary response to the Sb site of influenza virus hemagglutinin. Nonrandom silent mutation and unequal numbers of VH and Vk mutations. J Immunol. 1990 Oct 01; 145(7):2286-96.
    View in: PubMed
    Score: 0.006
  45. Heavy-chain class switch does not terminate somatic mutation. J Exp Med. 1990 Aug 01; 172(2):531-6.
    View in: PubMed
    Score: 0.006
  46. V region gene usage and somatic mutation in the primary and secondary responses to influenza virus hemagglutinin. J Immunol. 1990 Apr 01; 144(7):2795-801.
    View in: PubMed
    Score: 0.006
  47. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med. 1990 Jan 01; 171(1):265-92.
    View in: PubMed
    Score: 0.006
  48. In-silico cell surface modeling reveals mechanism for initial steps of B-cell receptor signal transduction. Mol Immunol. 2009 Sep; 46(15):3141-50.
    View in: PubMed
    Score: 0.006
  49. Analysis of VH gene replacement events in a B cell lymphoma. J Immunol. 1989 Jun 15; 142(12):4475-82.
    View in: PubMed
    Score: 0.006
  50. Interspersion of the VHQ52 and VH7183 gene families in the NFS/N mouse. J Immunol. 1989 Jun 15; 142(12):4483-92.
    View in: PubMed
    Score: 0.006
  51. Structural patterns in anti-DNA antibodies from MRL/lpr mice. Cold Spring Harb Symp Quant Biol. 1989; 54 Pt 2:933-46.
    View in: PubMed
    Score: 0.005
  52. Editing and escape from editing in anti-DNA B cells. Proc Natl Acad Sci U S A. 2008 Mar 11; 105(10):3861-6.
    View in: PubMed
    Score: 0.005
  53. How immunoglobulin V kappa genes rearrange. J Immunol. 1987 Dec 01; 139(11):3834-9.
    View in: PubMed
    Score: 0.005
  54. Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc Natl Acad Sci U S A. 1987 Dec; 84(24):9150-4.
    View in: PubMed
    Score: 0.005
  55. A complex translocation at the murine kappa light-chain locus. Mol Cell Biol. 1987 Nov; 7(11):4130-3.
    View in: PubMed
    Score: 0.005
  56. The role of clonal selection and somatic mutation in autoimmunity. Nature. 1987 Aug 27-Sep 2; 328(6133):805-11.
    View in: PubMed
    Score: 0.005
  57. Lupus susceptibility genes may breach tolerance to DNA by impairing receptor editing of nuclear antigen-reactive B cells. J Immunol. 2007 Jul 15; 179(2):1340-52.
    View in: PubMed
    Score: 0.005
  58. Variable region sequences of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors). II. Comparison of hybridomas derived by lipopolysaccharide stimulation and secondary protein immunization. J Exp Med. 1987 Apr 01; 165(4):970-87.
    View in: PubMed
    Score: 0.005
  59. Variable region sequences of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors). A structural explanation for the high frequency of IgM anti-IgG B cells. J Exp Med. 1986 Aug 01; 164(2):407-27.
    View in: PubMed
    Score: 0.005
  60. Recombination between an expressed immunoglobulin heavy-chain gene and a germline variable gene segment in a Ly 1+ B-cell lymphoma. Nature. 1986 Aug 28-Sep 3; 322(6082):843-6.
    View in: PubMed
    Score: 0.005
  61. Consequences of receptor editing at the lambda locus: multireactivity and light chain secretion. Proc Natl Acad Sci U S A. 2006 Jul 25; 103(30):11264-9.
    View in: PubMed
    Score: 0.005
  62. Development and selection of edited B cells in B6.56R mice. J Immunol. 2006 Jun 01; 176(11):6879-87.
    View in: PubMed
    Score: 0.005
  63. Control of genotypic allelic inclusion through TCR surface expression. J Immunol. 2005 Nov 15; 175(10):6412-9.
    View in: PubMed
    Score: 0.004
  64. Inter- and intraclonal diversity in the antibody response to influenza hemagglutinin. J Exp Med. 1985 Apr 01; 161(4):687-704.
    View in: PubMed
    Score: 0.004
  65. Genetic polymorphism at the kappa chain locus in mice: comparisons of restriction enzyme hybridization fragments of variable and constant region genes. Immunogenetics. 1985; 21(5):445-57.
    View in: PubMed
    Score: 0.004
  66. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. Proc Natl Acad Sci U S A. 1984 May; 81(10):3180-4.
    View in: PubMed
    Score: 0.004
  67. The idiotypes of V kappa 21 light chains. Ann Immunol (Paris). 1984 Jan-Feb; 135C(1):181-5.
    View in: PubMed
    Score: 0.004
  68. Dynamical analysis of a degenerate primary and secondary humoral immune response. Bull Math Biol. 2003 May; 65(3):535-45.
    View in: PubMed
    Score: 0.004
  69. Chronic graft-versus-host in Ig knockin transgenic mice abrogates B cell tolerance in anti-double-stranded DNA B cells. J Immunol. 2002 Apr 15; 168(8):4142-53.
    View in: PubMed
    Score: 0.003
  70. DNA between variable and joining gene segments of immunoglobulin kappa light chain is frequently retained in cells that rearrange the kappa locus. Proc Natl Acad Sci U S A. 1982 Jan; 79(2):262-6.
    View in: PubMed
    Score: 0.003
  71. Aberrant rearrangements contribute significantly to the allelic exclusion of immunoglobulin gene expression. Nature. 1981 Apr 02; 290(5805):372-8.
    View in: PubMed
    Score: 0.003
  72. The structural basis of antigenic determinants on V kappa 21 light chains. Mol Immunol. 1981 Jan; 18(1):1-9.
    View in: PubMed
    Score: 0.003
  73. Expression of kappa chains of the V kappa 21 group in Mus musculus and related species. Mol Immunol. 1981 Jan; 18(1):11-7.
    View in: PubMed
    Score: 0.003
  74. Reorganization and expression of immunoglobulin genes: status of allelic elements. Cold Spring Harb Symp Quant Biol. 1981; 45 Pt 2:925-33.
    View in: PubMed
    Score: 0.003
  75. Antibody gene linkage studies in (NZB X C58) recombinant-inbred lines. J Immunol. 1980 Feb; 124(2):787-9.
    View in: PubMed
    Score: 0.003
  76. The joining of V and J gene segments creates antibody diversity. Nature. 1980 Jan 31; 283(5746):497-9.
    View in: PubMed
    Score: 0.003
  77. Rearrangement of genetic information may produce immunoglobulin diversity. Nature. 1978 Dec 21-28; 276(5690):785-90.
    View in: PubMed
    Score: 0.003
  78. Plasmacytomas of the NZB mouse. J Immunol. 1978 Nov; 121(5):1969-72.
    View in: PubMed
    Score: 0.003
  79. Clone: a Monte-Carlo computer simulation of B cell clonal expansion, somatic mutation, and antigen-driven selection. Curr Top Microbiol Immunol. 1998; 229:173-97.
    View in: PubMed
    Score: 0.003
  80. A Shannon entropy analysis of immunoglobulin and T cell receptor. Mol Immunol. 1997 Oct; 34(15):1067-82.
    View in: PubMed
    Score: 0.002
  81. A solution to the rheumatoid factor paradox: pathologic rheumatoid factors can be tolerized by competition with natural rheumatoid factors. J Immunol. 1997 Aug 15; 159(4):1728-38.
    View in: PubMed
    Score: 0.002
  82. Genetic control of antibody variable regions. Cold Spring Harb Symp Quant Biol. 1977; 41 Pt 2:837-46.
    View in: PubMed
    Score: 0.002
  83. A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease. J Exp Med. 1996 Oct 01; 184(4):1269-78.
    View in: PubMed
    Score: 0.002
  84. Light chain contribution to specificity in anti-DNA antibodies. J Immunol. 1995 Sep 15; 155(6):3223-33.
    View in: PubMed
    Score: 0.002
  85. Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse. Nature. 1975 Aug 21; 256(5519):644-6.
    View in: PubMed
    Score: 0.002
  86. An isotype switched and somatically mutated rheumatoid factor clone isolated from a MRL-lpr/lpr mouse exhibits limited intraclonal affinity maturation. J Immunol. 1994 May 01; 152(9):4489-99.
    View in: PubMed
    Score: 0.002
  87. Immunochemical analysis of the idiotypes of mouse myeloma proteins with specificity for levan or dextran. J Exp Med. 1974 Jan 01; 139(1):137-47.
    View in: PubMed
    Score: 0.002
  88. Mouse lambda-chain sequences. Proc Natl Acad Sci U S A. 1973 Jul; 70(7):2112-6.
    View in: PubMed
    Score: 0.002
  89. Immunochemical analysis of the cross-reacting idiotypes of mouse myeloma proteins with anti-dextran activity and normal anti-dextran antibody. Proc Natl Acad Sci U S A. 1973 Jan; 70(1):235-9.
    View in: PubMed
    Score: 0.002
  90. Genetics of the antibody response to dextran in mice. Science. 1972 Jul 14; 177(4044):178-80.
    View in: PubMed
    Score: 0.002
  91. Selective pathogenicity of murine rheumatoid factors of the cryoprecipitable IgG3 subclass. Int Immunol. 1992 Jan; 4(1):93-9.
    View in: PubMed
    Score: 0.002
  92. Variability in the lambda light chain sequences of mouse antibody. Nature. 1970 Dec 12; 228(5276):1045-7.
    View in: PubMed
    Score: 0.002
  93. Aberrant rearrangement of the kappa light-chain locus involving the heavy-chain locus and chromosome 15 in a mouse plasmacytoma. Nature. 1983 Feb 03; 301(5899):425-7.
    View in: PubMed
    Score: 0.001
  94. Amplification of immunoglobulin lambda constant genes in populations of wild mice. Nature. 1982 Dec 23; 300(5894):757-60.
    View in: PubMed
    Score: 0.001
  95. Independent segregation of NZB immune abnormalities in NZB x C58 recombinant inbred mice. Eur J Immunol. 1982 Apr; 12(4):349-54.
    View in: PubMed
    Score: 0.001
  96. Transcription of the unrearranged mouse C kappa locus: sequence of the initiation region and comparison of activity with a rearranged V kappa-C kappa gene. Cell. 1981 Dec; 27(3 Pt 2):593-602.
    View in: PubMed
    Score: 0.001
  97. Identification and nucleotide sequence of a diversity DNA segment (D) of immunoglobulin heavy-chain genes. Nature. 1981 Apr 16; 290(5807):562-5.
    View in: PubMed
    Score: 0.001
  98. Myeloma proteins from NZB and BALB/c mice: structural and functional differences. Proc Natl Acad Sci U S A. 1979 Mar; 76(3):1395-9.
    View in: PubMed
    Score: 0.001
  99. A search for hapten-binding mouse plasmacytoma proteins. Eur J Immunol. 1979 Feb; 9(2):125-9.
    View in: PubMed
    Score: 0.001
  100. Comparisons of myeloma proteins from NZB and BALB/c mice: structural and functional differences of heavy chains. J Immunol. 1979 Jan; 122(1):44-8.
    View in: PubMed
    Score: 0.001
  101. Multiplicity of germline genes specifying a group of related mouse kappa chains with implications for the generation of immunoglobulin diversity. Nature. 1978 Dec 21-28; 276(5690):780-4.
    View in: PubMed
    Score: 0.001
  102. Immunoglobulins with hapten-binding activity: structure-function correlations and genetic implications. Eur J Immunol. 1978 Jul; 8(7):497-503.
    View in: PubMed
    Score: 0.001
  103. Chromosomal locations of mouse immunoglobulin genes. Proc Natl Acad Sci U S A. 1978 Jun; 75(6):2883-7.
    View in: PubMed
    Score: 0.001
  104. Genetics of mouse antibodies. I. Linkage of the dextran response locus, VH-DEX, to allotype. Eur J Immunol. 1975 Nov; 5(11):775-7.
    View in: PubMed
    Score: 0.001
  105. Genetics of mouse antibodies. II. Recombination between VH genes and allotype. Eur J Immunol. 1975 Nov; 5(11):778-81.
    View in: PubMed
    Score: 0.001
  106. Mouse immunoglobulin heavy chains are coded by multiple germ line variable region genes. Proc Natl Acad Sci U S A. 1974 Oct; 71(10):4096-100.
    View in: PubMed
    Score: 0.001
  107. Immunochemical studies on mouse myeloma proteins with specificity for dextran or for levan. Immunochemistry. 1972 May; 9(5):535-44.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.